Sphingolipids
Invitrogen™ NBD C6-Ceramide Complexed to BSA
Selective stain for Golgi apparatus in live and fixed cells
Invitrogen™ BODIPY™ FL C5-Ceramide (N-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Pentanoyl)Sphingosine)
Useful in cellular imaging and cell tracing and tracking
Invitrogen™ BODIPY™ TR Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ BODIPY™ FL C5-Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ NBD C6-Ceramide (6-((N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)amino)hexanoyl)Sphingosine)
Selective stain for Golgi apparatus in live and fixed cells
Invitrogen™ BODIPY™ FL C5-Lactosylceramide complexed to BSA
The green-fluorescent BODIPY™ FL C5 lactosylceramide complexed to BSA can be used in sphingolipid transport and metabolism mechanisms.
Apexbio Technology LLC Lyso-Tracker Red(Synonyms: LysoTracker Red DND-99, LysoTracker Red, LysoTracker Red fluorescent probe), 50ul, CAS: 231946-72-8.
Lyso-Tracker Red (CAS 231946-72-8) is a weakly basic fluorescent dye designed for labeling lysosomes in live cells. This cell-permeable molecule selectively accumulates within acidic lysosomal compartments due to protonation and subsequent entrapment in their low-pH environment. Unlike conventional lysosomal dyes such as neutral red and acridine orange, Lyso-Tracker Red displays superior organelle specificity, requiring nanomolar concentrations to clearly visualize lysosomes. Supplied as a 1 mM stock solution in DMSO, this probe is utilized for live-cell imaging studies investigating lysosomal function and trafficking pathways.
Cayman Chemical C16 Ceramide (d18:1/16:0), Purity: ≥98%, CAS: 24696-26-2, 10 mg
A sphingolipid; levels are increased by PPMP or MAPP in isolated human neutrophils and are correlated with an increase in apoptosis; accumulates in the lungs of patients with cystic fibrosis compared with the lungs of patients with pulmonary hypertension; plasma levels are increased in patients with acute coronary syndrome, and an increased plasma ratio of C16 to C24:0 ceramide is associated with major adverse cardiac events; levels are increased in tumor tissue from patients with breast cancer and is associated with metastatic cancer
Cayman Chemical C12 NBD Ceramide (d18:1/12:0), Purity: ≥98%, CAS: 202850-01-9, 1 mg
C12 NBD ceramide (d18:1/12:0) is a long-chain fluorescent ceramide analog that can be used for the measurement of alkaline and neutral ceramidase activity.{14063} It is hydrolyzed efficiently by alkaline ceramidase from P. aeruginosa and by neutral ceramidase from mouse liver. In addition, alkaline and neutral ceramidases from a variety of mammalian cell lines also hydrolyze C12 NBD ceramide (d18:1/12:0). Acid ceramidase does not appear to utilize C12 NBD ceramide (d18:1/12:0) as a substrate. The possibility exists forC12 NBD ceramide (d18:1/12:0) to also be applied to the measurement of ceramide kinase and/or sphingomyelin synthase activity.
Medchemexpress LLC C8 PEG750 Ceramide | 212116-76-2 | 99.94% | 1 MG
C8 PEG750 Ceramide is a lipid product designed to synthesize a lipid bilayer carrier. It enables the selective delivery of various diagnostic and therapeutic agents to acidic diseased cells.
- Synthesizes a lipid bilayer carrier
- Facilitates selective delivery of diagnostic and therapeutic agents
- Targets acidic diseased cells
Medchemexpress LLC C16 PEG2000 ceramide | 212116-78-4 | MFCD02265697 | 99.4% | (C2H4O)nC39H73NO6 | 10MG
C16 PEG2000 ceramide is a polyethylene glycol-conjugated C16 ceramide (PEG MW ≈2000) used as a PEGylated lipid in nanoparticle and liposome formulations to improve stability and delivery of hydrophobic agents. It is typically supplied as a white to off-white powder with reported high purity.
- Pegylated C16 ceramide for lipid formulations.
- Enhances stability of lipid nanoparticles and liposomes.
- Improves solubility and dispersibility of hydrophobic compounds.
- White to off-white powder form for ease of handling.
- High purity suitable for research applications.